Tabula Rasa HealthCare Completes the Sale of SinfoníaRx and DoseMeRx

MOORESTOWN, N.J., March 2, 2023 /PRNewswire/ — Tabula Rasa HealthCare, Inc.® (NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, today announced that it completed the sale of its SinfoníaRx business to Cureatr, following the sale of its DoseMeRx…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.